Reliable cost reduction with rooftop solar power generation at pharmaceutical factories! Up to 28% cut.
"A reliable solution for energy measures in pharmaceutical factories." With rooftop solar power generation, reduce electricity costs by up to 28%. Also strengthens BCP (Business Continuity Planning).
【Our Construction Numbers and Client List】 A total construction cost of 908.4 billion yen, with 83 solar power plants built over 12 years. Clients include Sharp, Panasonic, Daiwa House, Nomura Securities, Mitsubishi HC Capital, JA Mitsui Leasing, DMM.com, KKR, Macquarie Capital, Canadian Solar, Trina Solar, J Holdings, RE100 Power, Excelsior Japan, WindSmile, B&M Asset Management, AD Works, Sparks Asset Management, Etrion, and many others. Reduce costs and CO₂ simultaneously without stopping high-precision manufacturing equipment! 【Don't make mistakes! Points for choosing a reliable solar power construction contractor】 Catalog available! ■ Current Issues - Fluctuations in electricity prices directly impact manufacturing costs - Concerns about backup systems during power outages - Requests from clients for CO₂ reduction and ESG compliance ■ Changes After Implementation - Previously: Market-linked variable electricity prices + issues with emergency power supply - After implementation: Self-consumption from rooftop solar, reducing electricity costs by up to 28% → Achieving BCP measures for pharmaceutical lines and CO₂ emission reductions as well.
- Company：バリューイノベーションジャパン
- Price：Other
